In what ways does lipitor affect ldl cholesterol?

How does Lipitor lower LDL?

Lipitor works by blocking an enzyme called HMG-CoA reductase, the main rate-limiting step in cholesterol synthesis. By slowing production in the liver, the body responds by pulling LDL receptors to the surface of liver cells, which increases the count of receptors and clears more LDL particles from the blood.

What happens to LDL levels after starting Lipitor?

Clinical studies show that Lipitor reduces LDL by 39% to 60% depending on the dose. A 10 mg dose lowers LDL by roughly 39%, while 80 mg achieves reductions near 60%. Reductions appear within two weeks and stabilize by six weeks.

Why does Lipitor affect other lipid markers too?

Lipitor also modestly lowers triglyercides and raises HDL. Triglyceride reductions range from 19% to 37%, which occurs because cholesterol synthesis inhibition reduces VLDL production, thereby fewer VLDL particles convert into LDL. HDL gains are usually 5% to 9%.

When does Lipitor patent expire?

The primary patent on atorvastatin calcium, the active ingredient in Lipitor, expired in 2011. Since then, generic versions dominate the market. The company that made original Lipitor still holds some secondary patents on formulations, but those has expired too. [1]

Why are companies challenging this patent?

No active major patent disputes remain for Lipitor. Past disputes were over generic entry timing, but once the core patent expired in 2011, hundreds of manufacturers entered the market.

How does Lipitor compare with Crestor?

Crestor (rosuvastatin) produces stronger LDL reductions at comparable doses. For example, 10 mg Crestor achieves a 45% bis 46% reduction versus 39% for 10 mg Lipitor. Users who reach their LDL targets with Lipitor still often switch to Crestor for stiffer reductions or for better toleration in some patients.

Can biosimilars enter before patent expiry?

Lipitor is a small-molecule chemical drug, not a biological product. Therefore biosimilars are not applicable.